Dr. Naushad Ghilzai

Dr. Ghilzai is currently at Philadelphia College of Osteopathic Medicine (PCOM) School of Pharmacy in Suwanee, Georgia, holding Associate Dean for Academic Affairs and Interim Assistant Dean of Assessment and Program Quality positions. Dr. Ghilzai also served as the Founding Dean at the West Coast University School of Pharmacy in Los Angeles, California, for about 2 years. Earlier, Dr. Ghilzai served as an Assistant Professor at Chicago College of Pharmacy, Midwestern University in Downers Grove, Illinois, and Associate Profession and full Professor at LECOM School of Pharmacy in Erie, Pennsylvania, where he taught and oversaw the School’s faculty development as Associate Dean of Faculty Affairs at both campuses (Erie, PA and Bradenton, Florida).

Pursued B.Pharm and M.Pharm from University of Delhi 1981-87.

Dr. Shanthi Pal

Team Lead, Pharmacovigilance, Regulation and Prequalification, World Health Organization.

B.Pharm from Jamia Hamdard 1998-2001

Over the last two decades she has held many different positions at the World Health Organization, where she currently serves as the Programme Manager of the Medicines Safety group within the Safety & Vigilance Team. In this position she supports pharmacovigilance activities in low- and middle-income countries in priority programmes such as HIV, Tuberculosis and Malaria. Besides this, she is a WHO representative in platforms such as ICH, CIOMS, ICMRA, and a Deputy Board Member of the Uppsala Monitoring Centre in Sweden.

Mr. Anil Arora

Mr. Arora did Diploma in Pharmacy from Hamdard college of Pharmacy (1983-1987) after which he moved to DIPSAR for B.Pharm. He is the founder director at WINGS Pharmaceuticals Pvt. Ltd., WINGS Biotech Ltd., WINGS Novitas Healthcare LLP., WINGS BIOTECH Lifecare LLP. Wings Pharmaceuticals has been in business services from more than 35 years and the company’s authorized capital stands at about Rs. 510 lakhs and has Rs. 213.28 lakhs paid-up capital.

Dr. Arshad Khuroo

Head Bioavailability & Bioequivalence at SUN PHARMA.

Completed B.Pharm-1991-95 from Jamia Hamdard.

An effective leader with a significant contribution towards organizational growth, able to strategize and prioritize effectively to accomplish multiple tasks. Sound knowledge of GLP/ GCP guidelines, protocol designing, biopharmaceutical evaluation, project management and regulated bio-analysis towards conduct of pharmacokinetic and pharmacodynamic end point studies for ANDA/NDA fillings.

Asif Siddiqui

He is a senior medical leader with extensive global and regional experience in world leading organisations, a strategic mindset, keen business acumen, and passion for bringing innovative therapies to patients through effective internal and external collaboration. He has worked in organizations such as Roche as GMA leader Oncology (Basel Area, Switzerland); Fishawack Health as Director of Scientific Communications (Basel Area, Switzerland); Springer Nature Group as Editorial leader (Auckland, New Zealand) and in Sun Pharma as Medical Affairs Scientist.

B.Pharm and M.Pharm from Jamia Hamdard.

Dr. Manish Narang

Director Medical Affairs APAC at Abbott, B.Pharm; M.Pharm-1991-97

A multifaceted professional with more than 25 years’ experience in Cardiovascular Devices and Pharmaceutical Industry in different functional area including General Management | Human & Financial Strategy | Clinical Research | Medical Affairs, Regulatory & Reimbursement | KOL Management | Health Economics | Business Operations Management | Professional Education. A unique combination of Commercial & Scientific acumen and having a proven track record in setting up organizations in Asia Pacific Region.

Specialties: General Management, Clinical Research, Project Management, Professional Affairs, Medical Education, Regulatory Affairs

Anupam trehan

Senior Vice President at HealthKart Gurgaon, Haryana, India; Jamia Hamdard 1991 - 1997

Suneet Shukla

Senior Pharmacologist at FDA, Washington DC-Baltimore Area

He has also worked in National Cancer Institute (NCI) Bethesda, as Staff scientist (Oct 2010- Aug 2016). He is a Member of NIH Membrane Protein and FDA Transporter Interest, Office of Clinical Pharmacology Groups. Lead Instructor of Medical Pharmacology course, Instructor of Cell Membrane and Intracellular Trafficking course, Foundation for Advanced Education Graduate School, NIH.

He has completed BS (Pharmacy) in 1992-1996.

Dr. Tanveer Naved

Acting Principal & Head, Amity Institute of Pharmacy, Amity University Uttar Pradesh, Noida; Teaching-14 years; Research-16 years; Administration-04 years as Head of the Institute.

Jamia Hamdard B.Pharm: 1995

Dr. Shazli Ahmed Khan

Novartis; Franchise Head- Ophtha, Respiratory, Neuro and Pain; B.Pharm 1999-2003

Business Development, Alliance Management, Strategic Planning, Commercial Operations, Value & Access, Patient Advocacy, Sales and Marketing

Business Unit Leader at Novartis, out on a quest to reimagine access to innovative drugs and transform practice of medicine in Vietnam. Passionate about creating high-performing teams with shared goals and a purpose inspired by the thought- “none shall be denied”!!!Business

Mr. Puneet Tyagi

Associate Director at AstraZeneca Gaithersburg, Maryland, United States.

Responsible for design of custom drug delivery systems, adoption of emerging delivery technologies, and portfolio strategy. Building support with senior management for new delivery initiatives and influencing stakeholders to adopt delivery strategies for life cycle management.

Jamia Hamdard M.Pharm, Pharmaceutics 2001 - 2003

Dr. Asif Iqbal

Senior medical safety lead at NOVARTIS; Hyderabad, India

He has completed PhD from Texila American University Consortium; M.Pharm (2005 - 2007) and B.Pharm (2001 - 2005) from Jamia Hamdard.

His work profile includes: Periodic Safety Update Report (PSUR), Risk Management Plan (RMP) updates and associated activities, Safety signal detection, coordinating the management of large datasets for analysis purposes, responses to external authorities, review of clinical protocols and other regulatory activities, and responsibility for the clinical review and evaluation of cases including input for follow-up and data cleaning, within agreed timeframes and to a high standard of accuracy, in compliance with IMS business rules, standard operating procedures and global and local regulatory requirements.

Afzal Mohd.

Analytical Development and Regulatory support Team Lead. at AVALON Pharma; since 2017, in Saudi Arabia.

He has also worked in Tabuk pharmaceuticals manufacturing Co as Senior Analyst (Quality unit department) Jul 2013 - Aug 2017 (4 yrs 2 mos); in Dabur R &D Center as Research scientist from Sep 2009 - Jul 2013; and in Ranbaxy as Research Trainee from Aug 2008 - Apr 2009.

He completed his M.Pharm from Jamia Hamdard (2007-2009); and B.Pharm from Jamia Hamdard in Jan 2003-Jul 2007.

He is a dynamic pharmaceutical professional, with almost 12 years of experience in R&D and validation processes, Quality Management System. Proficient in Analytical development and research. He has expertise in managing functions related to Analytical R&D, product development, method optimization, in-process quality control, Brand analysis and decoding, documentation. Having other expertise like regulatory affairs and IPR in the field of pharmaceuticals (knowledge of FDA, EMEA, TGA, SFDA, GCC guideline etc) make more specific and compatible among pharmaceutical professionals.

Dr. Tahir Khuroo

Chief Scientific Officer, PGx Global Foundation, Houston, Texas, United States.

He is experienced Research Manager with a demonstrated history of working in the pharmaceuticals industry. Skilled in Nanomaterials, Liquid Chromatography-Mass Spectrometry (LC-MS), Cancer Research, and Nanoparticles.

He has completed M.Pharm (2011-2013) and Doctor of Philosophy - PhD focused in Pharmaceutics and Drug Design from Jamia Hamdard (2014-2019).